Baskins is one of a handful of astronauts to have worked for the United States Space Agency.
A longtime professor at Cornell University, he is now the chief scientific officer at the company he co-founded.
In a video message posted on Twitter earlier this month, Baskas said the new lab’s potential is exciting.
“Our work with the National Institutes of Health (NIH) has allowed us to develop tools that can be used by space exploration teams, for the first time, in a way that allows them to explore the full range of space-borne health problems,” he said.
“For the first, the best, and perhaps the last time, a physician will be able to treat space sickness in space.”
The lab uses specially engineered microbes to help treat astronauts’ gastrointestinal issues and other medical conditions.
“We’ve been able to demonstrate this capability, in combination with existing equipment, that can help astronauts recover from space sickness,” Baskers said in the video.
“The tools have been designed to allow astronauts to take their medications in space, and in the case of a space illness, to use them while on the International Space Station (ISS).”
Our tools allow them to take medication in space as they are flying to and from a space station, and they also allow them access to space medications in the event of a medical emergency.
It’s a great way to bring people back from space and to have them be able, once again, to have a great opportunity to be able back on Earth.””
I can’t wait to take the gloves off and see what they do when they’re not on the ground,” he added.
Baskins, a spaceflight enthusiast, has a degree in microbiology and biochemistry.
He’s also a former astronaut and astronaut on the first space shuttle mission.”
I love this, and I think that’s why the mission of the lab is so exciting,” Bawkins said.
The lab, called The Medical Lab, will be used for the space exploration community.
The space agency expects the new facility will be operational by 2022.”
We’ve seen a tremendous amount of interest from the private space industry, and we think that it’s going to be a huge boon to the country,” said John DeLong, director of the space agency’s Office of Space, in an interview with Bloomberg Television.
The agency has $10 billion in contracts to work with companies in space for its science missions, including the ISS, the International Astronautical Consortium (IAC) and the International Geophysical Year.
The IAC has also announced a partnership with the space lab.”
The space agency has been working on the development of a new version of the Microbiota-Based Diagnostics System (MBDAS) for astronauts, but Baskens’ lab is a first step toward testing the system in space. “
It’s a tremendous opportunity for the private sector, to get the opportunity to work on a new mission that they can leverage to help get people back home.”
The space agency has been working on the development of a new version of the Microbiota-Based Diagnostics System (MBDAS) for astronauts, but Baskens’ lab is a first step toward testing the system in space.
It is still in its infancy, but a prototype of the MBDAS is ready for launch this year, he said in a video posted on the NASA site.
“There are many ways that we can develop the MBDs to allow us to be more efficient in space medicine,” Basket said.
Bawkins, who is also a member of the scientific advisory board for the International Association for Microbial and Biomolecular Sciences, a group that advises NASA on biomedical science, is a leader in microbial technology.
He also has experience in diagnosing space sickness, and he said he is confident that the lab will be ready to address the problems that space travel poses to astronauts.
“The spaceflight community has been waiting for this for decades, and it’s just fantastic to be here at the beginning,” he told Bloomberg Television in a phone interview.
“This is a big step in the right direction.”
For more information on the space program, visit: https://www.nasa.gov/space